GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

Biophytis has expanded its existing partnership with LynxKite Technologies to accelerate AI-driven longevity drug discovery.

Novartis has received the US FDA approval for Cosentyx to treat paediatric patients aged 12 years and above with moderate to severe HS.

PsiQuantum has partnered with the National Cancer Center Japan to drive advancements in utility-scale quantum computing within drug discovery and oncology.

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing DMTs for Parkinson’s disease.

The World Health Organization (WHO) has outlined desired antibacterial characteristics for three priority infections.

PRISM BioLab has collaborated with Receptor.AI to integrate AI and physics-guided technologies in the discovery of orally ...

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Bavarian Nordic has signed a manufacturing agreement with SII, expanding its strategic partnership through a contract for its ...

Curatis has signed an exclusive licensing and development agreement with Neupharma for corticorelin to treat peritumoral ...